Jazz Pharmaceuticals 

Booth 346

JazzPharma.jpg

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is an international biopharmaceutical company focused on improving patients’ lives by identifying, developing and commercializing meaningful products that address unmet medical needs. The company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. In these areas, Jazz Pharmaceuticals markets Xyrem® (sodium oxybate) oral solution and Erwinaze® (asparaginase Erwinia chrysanthemi) in the U.S., and markets Erwinase® and Defitelio® (defibrotide) in countries outside the U.S.

jazzpharmaceuticals.com

2005 Market Street
Suite 2100
Philadelphia, PA 19103

Products & Services Categories

  • Recruiting - Staffing